CLINICAL RESEARCH: ACUTE MYOCARDIAL INFARCTION
Impact of Heterogeneity of Human Peripheral Blood Monocyte Subsets on Myocardial Salvage in Patients With Primary Acute Myocardial Infarction
Hiroto Tsujioka, MD,
Toshio Imanishi, MD, PhD*,
Hideyuki Ikejima, MD,
Akio Kuroi, MD,
Shigeho Takarada, MD, PhD,
Takashi Tanimoto, MD,
Hironori Kitabata, MD,
Keishi Okochi, MD,
Yu Arita, MD,
Kohei Ishibashi, MD,
Kenichi Komukai, MD,
Hideaki Kataiwa, MD,
Nobuo Nakamura, MD,
Kumiko Hirata, MD, PhD,
Atsuhsi Tanaka, MD, PhD and
Takashi Akasaka, MD, PhD
Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan
Manuscript received December 27, 2008;
revised manuscript received April 9, 2009,
accepted April 14, 2009.
* Reprint requests and correspondence to: Dr. Toshio Imanishi, Department of Cardiovascular Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama City, Wakayama 641-8510, Japan (Email: t-imani{at}wakayama-med.ac.jp).
Objectives: We examined whether distinct monocyte subsets contribute in specific ways to myocardial salvage in patients with acute myocardial infarction (AMI).
Background: Recent studies have shown that monocytes in human peripheral blood are heterogeneous.
Methods: We studied 36 patients with primary AMI. Peripheral blood sampling was performed 1, 2, 3, 4, 5, 8, and 12 days after AMI onset. Two monocyte subsets (CD14+CD16– and CD14+CD16+) were measured by flow cytometry. The extent of myocardial salvage 7 days after AMI was evaluated by cardiovascular magnetic resonance imaging as the difference between myocardium at risk (T2-weighted hyperintense lesion) and myocardial necrosis (delayed gadolinium enhancement). Cardiovascular magnetic resonance imaging was also performed 6 months after AMI.
Results: Circulating CD14+CD16– and CD14+CD16+ monocytes increased in AMI patients, peaking on days 3 and 5 after onset, respectively. Importantly, the peak levels of CD14+CD16– monocytes, but not those of CD14+CD16+ monocytes, were significantly negatively associated with the extent of myocardial salvage. We also found that the peak levels of CD14+CD16– monocytes, but not those of CD14+CD16+ monocytes, were negatively correlated with recovery of left ventricular ejection fraction 6 months after infarction.
Conclusions: The peak levels of CD14+CD16– monocytes affect both the extent of myocardial salvage and the recovery of left ventricular function after AMI, indicating that the manipulation of monocyte heterogeneity could be a novel therapeutic target for salvaging ischemic damage.
Key Words: chemokine monocyte myocardial salvage acute myocardial infarction
|
Abbreviations and Acronyms
| | AMI = acute myocardial infarction | | CK = creatine kinase | | CMR = cardiac magnetic resonance | | CRP = C-reactive protein | | LE = late enhancement | | LV = left ventricle | | LVEF = left ventricular ejection fraction | | MI = myocardial infarction | | MRI = magnetic resonance imaging | | PCI = percutaneous coronary intervention | | PlGF = placental growth factor | | SAP = stable angina pectoris | | UAP = unstable angina pectoris |
|
Related Articles
-
Peripheral Blood Monocyte Subset Assessment in Non–ST-Segment Elevation Myocardial Infarction Is Required
- Peter A. Kavsak and Allan S. Jaffe
J. Am. Coll. Cardiol. 2010 55: 169.
[Full Text]
[PDF]
-
Reply
- Toshio Imanishi, Hiroto Tsujioka, and Takashi Akasaka
J. Am. Coll. Cardiol. 2010 55: 169-170.
[Full Text]
[PDF]
-
Monocyte Diversity in Myocardial Infarction
- Eduard Shantsila and Gregory Y.H. Lip
J. Am. Coll. Cardiol. 2009 54: 139-142.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A24.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, G. K. Feld, B. H. Greenberg, J. Hall, M. Hlatky, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, et al.
Highlights of the Year in JACC 2009
J. Am. Coll. Cardiol.,
January 26, 2010;
55(4):
380 - 407.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Kavsak and A. S. Jaffe
Peripheral Blood Monocyte Subset Assessment in Non-ST-Segment Elevation Myocardial Infarction Is Required
J. Am. Coll. Cardiol.,
January 12, 2010;
55(2):
169 - 169.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Shantsila and G. Y.H. Lip
Reply
J. Am. Coll. Cardiol.,
January 12, 2010;
55(2):
170 - 171.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Imanishi, H. Tsujioka, and T. Akasaka
Reply
J. Am. Coll. Cardiol.,
January 12, 2010;
55(2):
169 - 170.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Shantsila and G. Y.H. Lip
Monocyte Diversity in Myocardial Infarction.
J. Am. Coll. Cardiol.,
July 7, 2009;
54(2):
139 - 142.
[Full Text]
[PDF]
|
 |
|
|